Johnson & Johnson (NYSE:JNJ) is facing unexpected delays in the manufacturing of its coronavirus vaccine and may not be able to supply the doses it promised the federal government by spring, the New York Times reported on Wednesday. U.S. federal officials have been told that J&J has fallen as...
Read More